SCHEMBL580570

SCHEMBL580570

Cc1cc2oc3cc(O)c(O)c(F)c3c2c(=O)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.51
PTGS2 P35354 3/20 0.51
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.44
ANTXR2 P58335 1/20 0.44
NUAK1 O60285 2/20 0.43
IGF1R P08069 2/20 0.43
PIM1 P11309 2/20 0.43
SRC P12931 2/20 0.43
KDR P35968 2/20 0.43
PLK1 P53350 2/20 0.43
PKN1 Q16512 2/20 0.43
AURKB Q96GD4 2/20 0.43
ALK Q9UM73 2/20 0.43
MET P08581 1/20 0.43
AXL P30530 1/20 0.43
NEK2 P51955 1/20 0.43
PTK2 Q05397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10181447 0.85 PTGS1 (0.65) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10182556 0.84 NUAK1 (0.56) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10135385 0.81 MAOA (0.54) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL580976 0.81 KDM4E (0.44) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10181886 0.79 PTGS1 (0.49) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10181747 0.79 MGAM (0.57) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10135387 0.79 KDM4E (0.50) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL580508 0.77 KDM4E (0.47) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL580862 0.76 KDM4E (0.64) PTGS1PTGS2KDM4EMEN1KMT2A
SCHEMBL10181683 0.74 KDM4E (0.45) PTGS1PTGS2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121141-B1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (DE) 2012-02-15 EP claimed
US-20100330009-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS CIBA CORPORATION (US) 2010-12-30 US claimed
EP-2121141-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (DE) 2009-11-25 EP claimed
WO-2008110465-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (CH) 2008-09-18 WO claimed
US-8383088-B2 Coumestan-like antioxidants and UV absorbants BASF SE (DE) 2013-02-26 US disclosed
EP-2121141-B1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (DE) 2012-02-15 EP disclosed
US-20100330009-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS CIBA CORPORATION (US) 2010-12-30 US disclosed
EP-2121141-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (DE) 2009-11-25 EP disclosed
WO-2008110465-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS BASF SE (CH) 2008-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330009-A1 COUMESTAN-LIKE ANTIOXIDANTS AND UV ABSORBANTS TYR, NQO1, SIRT3 PTGS1 754/4885PTGS2 1477/4885KDM4E 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.